BBSRC ICURe Explore 2026: Closed £35,000 Market Exploration Grant Reference

You know that moment in a lab meeting when someone says, “This could be huge,” and everyone nods… and then you all go back to pipetting because nobody has time to figure out who would actually buy it, use it, approve it, or pay for it? That’s the gap BBSRC ICURe Explore was built to close.

ICURe Explore 2026 was not a research grant in the traditional “more experiments, more data” sense. It was funding for a different kind of work: getting out of the building (politely, productively) to test whether a bioscience-based idea had a real market and a real customer problem behind it. Think of it as a structured reality check—with cash attached.

Status: Closed 2026 cycle

The official UKRI opportunity page lists BBSRC ICURe Explore 2026 as closed. Its closing date was 6 February 2026 at 11:59pm UK time, and the page does not announce a later BBSRC ICURe Explore round. This page is therefore a historical reference, not a live application listing. Do not treat the retained deadline as a future date, and do not assume that the 2026 application route remains open.

The 2026 programme was designed for bioscience PhD students, researchers, and technicians who already had something promising—maybe a tool, method, platform, assay, software, therapeutic angle, synthetic biology approach, or enabling technology—but needed evidence that the outside world cared. Not just a supervisor or collaborators. The outside world: clinicians, pharma, food producers, diagnostics labs, regulators, procurement teams, and the people who sign purchase orders.

Here’s the kicker: applicants had to have completed ICURe Discover. That prerequisite was doing applicants a favour. It meant they were not walking in cold—they were building on earlier training and momentum, and reviewers could assume they understood the basics of market exploration rather than treating “customer discovery” like an exotic new species.

At a Glance: ICURe Explore 2026 Key Facts

What This Opportunity Actually Pays For (and Why That Matters)

The headline number—up to £35,000—was useful, but the structure is what made ICURe Explore unusually practical.

First, it included up to £20,000 for the Entrepreneurial Lead’s salary. Translation: someone could be paid to do the unglamorous, high-value work of talking to potential customers, mapping routes to market, and stress-testing assumptions. This mattered because commercial exploration is time-consuming in a way that doesn’t show up on a CV. Without dedicated time, it becomes “something I’ll do after I finish this experiment,” which is academic code for “never.”

Second, there was up to £15,000 for market discovery activities and business adviser support. That phrase can sound like consultant-speak, so let’s pin it down. Assumption testing is simply identifying what you are guessing—about the user, the problem, the performance requirements, the regulatory path, adoption barriers, pricing, competitors—and then gathering evidence to prove or disprove those guesses.

Customer discovery is the engine that powers that evidence. It might include travel to visit stakeholders, attending a targeted industry event (not the generic conference buffet circuit), developing simple prototypes or demos, paying for small bits of market research, or running tightly scoped validations.

In other words, ICURe Explore funds the work that turns “this is interesting science” into “this solves a painful problem for a defined group of people, and here’s proof.”

What ICURe Explore Is Not (So You Do Not Waste Your Time)

Let’s be blunt because deadlines are real: this is not a grant to extend your research project. If your plan is “run more experiments and then maybe someone will want it,” you’ll struggle.

It’s also not a blank cheque for building a polished product. ICURe Explore sits earlier than that. You’re testing demand, use-cases, and feasibility in the market sense—before you spend a year building something nobody asked for.

And it’s not a solo hero mission. Even if you’re the Entrepreneurial Lead, your project should show signs of being anchored in an institution that can support translation: tech transfer, business engagement, an innovation office, or a credible pathway to the next stage.

Who Was Eligible for the 2026 Cycle (with Real-World Fit Checks)

ICURe Explore 2026 was aimed at bioscience researchers and technicians based in eligible UK organisations—UK universities, BBSRC-funded institutes, and BBSRC-approved public sector research enterprises—who had already completed ICURe Discover. The official list included PhD students, postdoctoral research associates, researchers in fellowships and group leader positions, and research technical professionals.

If you’re wondering whether your idea is “commercial enough,” here’s a more helpful question: Can you point to a specific group of people who have a recurring, expensive, regulated, risky, or time-draining problem—and explain how your idea improves their situation? If yes, you’re in the right neighbourhood.

The 2026 programme was a particularly good fit for applicants who:

Were PhD students with an invention hiding inside a thesis. Maybe it was a faster screening assay, a new bioprocessing method, a smarter microbial engineering workflow, or a diagnostic concept. A finished company was not required; the key need was credible market evidence.

Were postdocs or research staff members sitting on a platform technology. Platform technologies are notorious for being “applicable to everything,” which is another way of saying “hard to sell to anyone.” ICURe Explore gave teams a structure to pick the strongest initial wedge: one customer segment, one urgent use-case, one set of proof points.

Were technicians or research specialists who knew how the work really happened. Technicians often see operational pain points that PIs miss: bottlenecks in sample handling, QC failures, workflow gaps, instrument downtime, compliance headaches. Those can be the exact problems customers will pay to solve—if documented properly.

The work also suited people who could hear “no” without spiralling. Customer discovery is rejection therapy with a spreadsheet. It is valuable when treated as data rather than a referendum on personal worth.

The Big Idea: Market Exploration as a Scientific Method

If “commercialisation” makes you itch, reframe it. ICURe Explore is basically applying the scientific method to the market.

• Your “hypothesis” is your value proposition.
• Your “experimental design” is your interview plan and assumption tests.
• Your “results” are patterns across stakeholders, not p-values.
• Your “conclusion” is a clearer route to impact—whether that’s licensing, a spinout, partnership, or even a decision to park the idea.

This is why the programme is worth your time even if you don’t end up founding a company. The skills travel with you.

Insider Tips for a Winning ICURe Explore Application

1) Write your assumptions like you mean it

Most applicants hide their assumptions in vague language: “There is significant demand for…” No. List the assumptions plainly and make them testable. For example: “Quality managers in mid-size biotech CDMOs will pay £X per year to reduce contamination events by Y%” is scary-specific—and that’s exactly why it’s useful.

2) Pick a customer segment and commit

You can always expand later. For Explore, choosing “healthcare” or “agriculture” is like choosing “planet Earth.” Instead, narrow: hospital microbiology labs, dairy processors, insect protein producers, cell therapy manufacturers, plant breeders, water utilities. Reviewers want focus because focus is how you learn quickly.

3) Make your Entrepreneurial Lead role look real, not ceremonial

The funding explicitly supports the Entrepreneurial Lead salary. Use that fact. Explain what that person will do week-to-week: number of interviews, stakeholder mapping, iteration cycles, validation activities. Make it feel like a job plan, not a title.

4) Show you understand adoption friction

In bioscience, the barrier is rarely “does it work?” It’s “can we validate it, integrate it, certify it, train staff on it, and justify buying it?” Address practical blockers early: regulatory classification, procurement cycles, compatibility with existing workflows, sample requirements, cold chain constraints, data governance, IP position.

5) Treat interviews as an experiment, not a chat

A strong customer discovery plan doesn’t say “we’ll talk to industry.” It says how many conversations, with whom, and what you’re trying to learn from each cohort. Mix your stakeholders: end users, buyers, influencers, and gatekeepers (hello, compliance and IT).

6) Budget like an adult, not like a wish list

The Explore budget categories are clear: salary plus customer discovery and testing costs. Build a budget that matches your learning goals. If travel is central, explain why in-person meetings are necessary (often true in regulated settings). If you need a prototype, keep it minimal and tied directly to validation.

7) Build a bridge to “what next”

Even if the programme doesn’t demand a full commercial plan, your application should hint at the next stepping stone: licensing discussions, seed funding, an accelerator, a translational grant, an industrial partner. You’re not promising a unicorn. You’re showing momentum and direction.

2026 Application Timeline: What the Closed Cycle Required

For the closed 2026 cycle, applicants worked backwards from the 6 February 2026 (23:59) deadline. The official page recorded an opening date of 8 December 2025, followed by a welcome call on 2 March 2026, bootcamp sessions on 4 to 5 March 2026 and 9 to 10 March 2026, and an options roundabout on 10 to 11 June 2026. Those dates describe the completed cohort; they are not a schedule for a new round.

For a future announcement, the useful planning lesson is to have the core narrative stable well before the closing date: what the problem is, who has it, why they care, and what the team will do during Explore to test the riskiest assumptions. Pressure-test the plan with people outside the lab—innovation office staff, an industry contact, or someone who has done ICURe before. If they cannot repeat the value proposition back, the application needs work.

Late January should be for tightening: sharpening the scope, aligning your budget with activities, and making sure the Entrepreneurial Lead time is credible. In the final week, do a compliance pass—eligibility, prerequisite completion (ICURe Discover), attachments, formatting, and internal sign-off if your organisation requires it. Submit at least 48 hours early; online portals have a nasty sense of humour.

Required Materials: What to Prepare (and How to Make It Strong)

UKRI opportunities often come with specific forms and templates, so treat the official page as your source of truth. In practical terms, expect to prepare:

• A project description that explains the bioscience idea, the proposed application(s), and—crucially—the market problem you’re testing. Your best friend here is clarity: a tight problem statement beats a beautiful paragraph of science.
• A customer discovery and assumption testing plan describing who you will speak to, what you need to learn, and how those insights will change your decisions. Mention numbers. Mention stakeholder types. Mention how you’ll capture and analyse insights.
• A budget and justification that clearly splits salary support and activity costs. Reviewers want to see that the money buys learning, not just motion.
• Evidence of eligibility and prerequisite completion, especially that you’ve finished ICURe Discover.
• Any supporting statements your organisation requires (for example, confirming institutional support or sign-off). Even if it’s not formally required, demonstrating that your tech transfer or innovation team is aware of the plan reduces perceived risk.

What Makes an Application Stand Out to Reviewers

Successful ICURe Explore applications feel grounded in reality. Not cynical—just evidence-based.

Reviewers tend to respond well when the problem is urgent and expensive, the customer is identifiable, and the proposed discovery work is designed to reduce the biggest uncertainties fast. They also like teams who don’t confuse “market size” with “market access.” You can claim a billion-pound market in one sentence; getting a first buyer is the hard part. Show you understand that.

A standout application also respects the difference between an invention and a product. Your technology might be brilliant, but the programme is about fit: fit with workflows, incentives, regulation, and purchasing behaviour. If you demonstrate you’re ready to learn—not just to persuade—you’ll read as fundable.

Common Mistakes to Avoid (and How to Fix Them)

Mistake 1: Trying to serve everyone. Fix: Pick one beachhead market. Name it. Describe it. Make the first use-case painfully specific.

Mistake 2: Writing like a paper instead of a plan. Fix: Replace literature-style background with a clear set of assumptions, risks, and tests. Market exploration is not a review article.

Mistake 3: Confusing interest with commitment. Fix: In interviews, don’t ask “Would you use this?” Ask what they do now, what it costs them, what happens when it fails, and what would make them switch.

Mistake 4: Ignoring the buyer. Fix: End users love things. Buyers buy outcomes. Identify who holds the budget and what they’re measured on.

Mistake 5: Overbuilding too early. Fix: Build the smallest demo that answers a question. “Can it work in their setting?” beats “Can we make it pretty?”

Mistake 6: Forgetting IP and freedom to operate. Fix: You don’t need a full patent strategy in Explore, but you should show you’ve spoken to the right people internally and understand what’s protectable and what might be crowded.

Frequently Asked Questions

Do I need to be a PI to apply?

Not necessarily. ICURe Explore is open to PhD students, researchers, and technicians in eligible organisations. The key is that your organisation can support the application and you meet all requirements, including completing ICURe Discover.

Is this only for UK universities?

No. Eligibility includes UK universities, BBSRC-funded institutes, and UKRI-approved public sector research enterprises.

What does completed ICURe Discover mean in practice?

It means you’ve previously gone through the ICURe Discover stage. If you’re not sure whether your participation counts as “completed,” ask using the contacts listed on the opportunity or your local programme lead before you spend hours drafting.

Can the £35,000 be used for lab reagents or new experiments?

This funding is described for market exploration, with budget lines for Entrepreneurial Lead salary and assumption testing/customer discovery activities. If you’re proposing lab work, justify it as essential validation tied directly to customer discovery—not as general research.

What is customer discovery, really?

It’s structured learning through conversations and evidence gathering with the people involved in using, buying, approving, or recommending your innovation. You’re looking for patterns: repeated pain points, constraints, purchasing triggers, and deal-breakers.

How competitive is it?

Programmes like this tend to be competitive because the value is high and the funding is targeted. The upside is that a focused, well-designed exploration plan can beat a flashier technology with a fuzzy market story.

Can this lead to a spinout or licensing deal?

Yes—those are common “next steps” if the evidence supports it. ICURe Explore doesn’t force you into one route, but it should help you make a smarter choice about which path actually fits.

Who do I contact with questions?

You’ve got three listed contacts: ciaran@thehelixway.com, info@thehelixway.com, and kcu@bbsrc.ukri.org. Use them—asking an eligibility question early is faster than rewriting an application late.

How the 2026 Cycle Accepted Applications

The 2026 route was through Innovate UK Business Connect, as linked from the official UKRI page. Before that cycle closed, applicants needed to confirm two gatekeepers: their organisation was eligible, and they had completed ICURe Discover. The application also needed organisational agreement, including the Entrepreneurial Lead’s ability to commit to the programme full-time.

The application plan should have covered the customer segment, the problem, current alternatives, and what would have to be true for adoption. It should also have explained the bioscience innovation, the proposed market exploration, the team’s roles, and the previous BBSRC or other UKRI grant underpinning the work. If the proposal was based on PhD research, the official guidance asked applicants to identify the PhD funder.

The customer discovery plan needed to show how the team would test value propositions through market engagement, including research with supply-chain participants, regulators, customers, and competitors. A concrete target for stakeholder conversations, a way to capture learning, and decision points for changing course would make the plan more credible than a promise to “talk to industry.”

Finally, the budget needed to map directly to learning milestones. The official award structure allowed up to £20,000 for the Entrepreneurial Lead’s salary and up to £15,000 for market discovery activities and business adviser support. A cost that did not buy useful information or support the required programme participation was difficult to justify.

The 2026 application window has ended. For any future BBSRC ICURe announcement, use the organisation’s current UKRI opportunity page and its linked Innovate UK Business Connect application route rather than relying on this archived cycle. The official 2026 reference remains here: https://www.ukri.org/opportunity/bbsrc-innovation-to-commercialisation-of-university-research-icure-explore-2026/